$MEDS News
Last published 2d ago
- 2d agoMEDSDataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion PolicyACCESS NewswireDataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx™ artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that its Corexa Pharmacy subsidiary has completed its first commercial sale of one of the ...
- 6d agoMEDSDataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMOACCESS NewswireNFL Alumni Health to support HMO member engagementRelationship centers on improving member GLP-1 related outcomes through use of the Health Lives Here app and easy access to telehealth, pharmacy and lab testing
- 1w agoMEDSDVLTDataMEDS AI Announces Termination of Second Amended and Restated Letter of IntentACCESS NewswireTAMPA, FL / ACCESS Newswire / November 3, 2026 / DataMeds AI, Inc. , a healthcare company that integrates its health information
- 1w agoMEDSDataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory CommitteeACCESS NewswireCorexa Pharmacy to dispense compounded BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax in accordance with HHS' recently updated Enforcement Discretion PolicyBulk drug substance access facilitates 3PL division's
- 2w agoMEDSDataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy NetworkACCESS NewswireBeing marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026Program will aim to bring best practices for respiratory
- 2w agoDVLTMEDSDatavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology LicenseBusiness WireExpanded healthcare platform would bring together patient-controlled data tokenization, biometric medication verification, and automated delivery technologies Datavault AI Inc. ("Datavault AI" or the
- 2w agoMEDSSCLXDVLTDataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain TechnologiesACCESS NewswireProprietary IP Position Until At Least 2042 to Enable Consolidation of Infrastructure targeting market expected to grow from $9.6 billion in 2025 to $93.4 billion in 2035Customer Acquisition Plan Leverages Existing
- 3w agoMEDSDVLTDataMeds Regains Compliance With NASDAQ Listing StandardsACCESS NewswireTAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. , a healthcare company leveraging its Health
- 3w agoMEDSDVLTDataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides RoadmapACCESS NewswireCorexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market TAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc.
- 4w agoMEDSDVLTDataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management PlatformACCESS NewswirePlatform to be integrated into Health Lives Here app as a subscription offering TAMPA, FL / ACCESS Newswire / October 14, 2026 / DataMeds AI, Inc. ("DataMeds AI," "DataMEDS SI,"
- 4w agoMEDSDVLTDataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology DivisionACCESS NewswireLeading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx® Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL / ACCESS Newswire
- 1mo agoMEDSDVLTDataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic CancersACCESS NewswireHumana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy TAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc. ("DataMeds AI," "DataMEDS SI,"
- 1mo agoMEDSDVLTDatameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I PaymentACCESS NewswireHealthcare IT Company and its Subsidiary Undertake Action Following US Government's Updated Nomenclature TAMPA, FL / ACCESS Newswire / October 5, 2026 / DataMeds AI, Inc. ("DataMeds AI,"
- 1mo agoMEDSDVLTDataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly RevenueACCESS NewswireSeptember 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launches TAMPA, FL / ACCESS Newswire / October 1, 2026 /
- 1mo agoMEDSDVLTDataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile ApplicationACCESS NewswireHealthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services TAMPA, FL / ACCESS Newswire / September 28, 2026 / DataMeds AI, Inc.
- 1mo agoMEDSDVLTDataMEDS AI To Present At 2026 National Telehealth and Virtual Care SummitACCESS NewswireInterim Co-CEO to Discuss Growing Patient Desire to Own Health Data TAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. ("DataMeds AI," "DataMEDS," or the
- 1mo agoMEDSDVLTDataMEDS AI Unveils New Corporate WebsiteACCESS NewswireUpdated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement TAMPA, FL / ACCESS Newswire / September 21, 2026 / DataMEDS
- 1mo agoMEDSDVLTDataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common SharesskedACCESS NewswireTAMPA, FL / ACCESS Newswire / September 18, 2026 / DataMeds AI, Inc. , a healthcare company leveraging its Health IT and physical
- 1mo agoMEDSAGPUDataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe ComputeACCESS NewswireAcquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer Management Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand
- 1mo agoAGPUMEDSAxe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platformGlobeNewswirePITTSBURGH, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ:AGPU) ("Axe Compute" or the "Company"), a neocloud AI infrastructure platform, today announced the sale of its legacy artificial
- 2mo agoMEDSDVLTDatameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign RolloutACCESS NewswireLeading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App Leading Healthcare IT
- 2mo agoMEDSCORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)ACCESS NewswireThis version includes the correct image.50% off available online at www.TolloHealth.Shop and www.CorexaRx.comSoon to become available at Health Lives Here™ pharmacies and on Amazon.com TAMPA, FL / ACCESS Newswire /
- 2mo agoMEDSDataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)ACCESS Newswire50% off available online at www.TolloHealth.Shop and www.CorexaRx.comSoon to become available at Health Lives Here™ pharmacies and on Amazon.com TAMPA, FL / ACCESS Newswire / August 27, 2026 / DataMeds AI, Inc.
- 2mo agoMEDSDVLTDataMeds AI Reports Second Quarter 2026 Financials and Provides Business UpdateACCESS NewswireRevenues grew 14% reaching $1.779M in Q2/26, beating management projectionsCorporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from 'WGRX' to
- 2mo agoMEDSDataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026ACCESS NewswireTAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. , an integrated healthcare company leveraging its Health IT
- 3mo agoMEDSDataMeds AI Provides Update on Corexa Health's Pharmacy DivisionACCESS NewswireGLP-1 agonist drugs now availableIntegration of online store CorexaRx.com into Health Lives Here app now completeMedical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now availableRevenue stabilized
- 3mo agoMEDSDVLTDataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health DivisionACCESS NewswireTAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. , a Health IT company leveraging its artificial intelligence platform
- 3mo agoMEDSDataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record DateACCESS NewswireTAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. , a Health IT company leveraging its artificial intelligence platform
- 3mo agoMEDSDataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"ACCESS NewswireInitiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient engagement tools
- 3mo agoMEDSDataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)ACCESS NewswireLaunch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. ,
- 3mo agoMEDSDVLTDataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization LicenseACCESS NewswireData monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX PlatformHealthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS
- 3mo agoDVLTMEDSDatavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AIBusiness WireDatavault AI extends data monetization and real-world asset tokenization technologies into the DataMeds AI’s EinsteinRX Platform Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT
- 3mo agoMEDSDVLTDataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to StockholdersACCESS NewswireTAMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., ), a health information technology leader implementing EinsteinRx™ artificial intelligence
- 3mo agoMEDSWGRXDataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital MarketsACCESS NewswireTrading under new symbol completes corporate rebranding from prior corporate name Wellgistics Health TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS,
- 5mo agoMEDSSCNXSCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYCACCESS NewswireCOMMACK, NY / ACCESS Newswire / June 4, 2026 / SCIENTURE HOLDINGS, INC. , a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients,
- 5mo agoDVLTMEDSSCLXWGRXWellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo HealthBusiness WireFormation of DelivMeds AI, Inc. (NASDAQ:MEDS), with an expected approximate combined asset value of $4 billion, is subject to an independent fairness opinion. Fully binding term sheet between Datavault AI
- 1y agoMEDSWGRXWellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder ValueACCESS NewswireTAMPA, FLORIDA / ACCESS Newswire / May 28, 2025 / Wellgistics Health, Inc. , a healthcare infrastructure company transforming the prescription drug ecosystem, today announced key additions to its executive
- 1y agoMEDSOGENOragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEOGlobeNewswireSARASOTA, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE:OGEN), a biotechnology company advancing innovative treatments for brain-related health conditions, today provided an update on its strategic
- 2y agoMEDSSCNXTRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to "SCNX"GlobeNewswireTRxADE Health, Inc. today announced that it changed its name and ticker symbol to "Scienture Holdings, Inc." and "SCNX", respectively, and that the business will continue as a Nasdaq-listed company. TAMPA, FL, Sept.
- 2y agoMEDSTRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.GlobeNewswireTAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. ("TRxADE") (NASDAQ:MEDS) and Scienture, LLC ("Scienture"), a wholly owned subsidiary of TRxADE, today announced that it is changing its
- 2y agoMEDSTRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership TeamGlobeNewswireTAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. ("TRxADE") (NASDAQ:MEDS) and Scienture, LLC ("Scienture"), a wholly owned subsidiary of TRxADE, today announced the appointment of
- 2y agoMEDSTRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 MillionGlobeNewswireScienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction valued at $103 million. TAMPA, FL and COMMACK, NY, July
- 2y agoMEDSTRxADE Health, Inc. Announces Special Cash DividendGlobeNewswireTAMPA, FL, July 09, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ:MEDS) (the "Company"), announced that the Company's board of directors has declared a special cash dividend of $1.50 per share of common stock.
- 2y agoMEDSTRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset SaleGlobeNewswireTAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (NASDAQ:MEDS) (the "Company"), announced today that with the filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "Form
- 2y agoMEDSTRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QGlobeNewswireTAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (the "Company"), announced that, on May 23, 2024, the Company received a notice (the "Notice") from the Nasdaq Listing Qualifications
- 2y agoMEDSTRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KGlobeNewswireTAMPA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (the "Company"), announced that, on April 17, 2024, the Company received a notice (the "Notice") from the Nasdaq Listing Qualifications
- 2y agoMEDSTRxADE Health, Inc. Announces Special Cash DividendGlobeNewswireTAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (NASDAQ:MEDS) (the "Company"), announced that the Company's board of directors has declared a special cash dividend of $8.00 per share of common stock.
- 2y agoMEDSTrxade health, Inc files its 3Q 10QGlobeNewswireTAMPA, FL, Jan. 17, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE"), a parent company of pharmaceutical business-to-business exchange platform, announced today that it filed its Quarterly Report
- 2y agoMEDSTRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.GlobeNewswireTAMPA, FL, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE"), a parent company of a pharmaceutical business-to-business exchange platform, announced today that it received a notice of
- 3y agoMEDSTrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.GlobeNewswireTAMPA, FL, Oct. 17, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE"), a parent company of pharmaceutical business-to-business exchange platform, which recently merged with Superlatus, Inc.